Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 24/10/20021 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Amendment
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending a previous determination of the regulatory review period for MIFEPREX that appeared in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to received comments. FDA is publishing notice of that amendment as required by law.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →